Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis. Ravikumar B, Crawford D, Dellovade T, Savinainen A, Graham D, Liere P, Oudinet J-P, Webb M, Hering H Neuropharmacology. 2016 Mar 30. PMID: 27039042. Abstract CommentRecommendBookmarkWatch